New small molecule inhibitors of arenaviruses
Award amount
$598,297Program and phase
STTR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- MICROBIOTIX, INC.
- Proposal award date
- 2014-02-15
- Contract end date
- 2017-01-31
- UEI
- SCNKBDM341T1
- Solicitation number
- PA10-124
- Topic code
- R
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infections
- Discovery of Bunyaviral Endonuclease Inhibitors for Anti Viral
- Development of well tolerated novel Inhibitors of drug resistant CMV
- Proof of concept experiments for T3SS inhibitors against burn wound infections
- Development of antibody drug conjugates as pan-filo antivirals
Research funding history
85 SBIR/STTR records share this UEI (2001–2025). Reported award amounts total $75,824,388. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services